Facebook
X
LinkedIn
ForwardManaging Toxicities of Immunotherapies (Enduring 2025)
In support of improving patient care, Duke University Health System Clinical Education and Professional Development is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME), to provide continuing education for the health care team. The designation was based upon the quality of the educational activity and its compliance with the standards and policies of the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC).
Program Description: DCI APP Chemotherapy Prescribing Lecture Series 2025 (Enduring) Core requirements for qualification to prescribe chemotherapy for advances practice providers and clinical pharmacists' providers.
Target Audience
Nurse Practitioners
Physician Assistants
Pharmacists
Physicians
Learning Objectives
Reviewing mechanism of immunotherapy agents in cancer treatment
Describing common and serious immune-related adverse events (irAEs)
Explaining role of steroids and other management strategies of immune-related adverse events (irAEs)
Summarizing treatment considerations with prolonged immunosuppression
Theresa Brown
ACPE - Pharmacist
AMA PRA Category 1 Credit(s)
ANCC
JA Credit - AH
Available Credit
- 1.00 ACPE - Pharmacist
- 1.00 AMA PRA Category 1 Credit(s)™
- 1.00 ANCC
- 1.00 Attendance
- 1.00 JA Credit - AH
- 1.00 Approved for AMA PRA Category 1 Credit(s)™